No Data
No Data
The Tokyo Stock Exchange's Gross index rebounded after 4 days, with major stocks rising despite Sanbio being at the limit-down.
Tokyo Stock Exchange Growth Market Index 822.90 +10.71 / Volume of 159.8 million shares / Trading value of 153.4 billion yen Tokyo Stock Exchange Growth Market 250 Index 638.15 +9.47 / Volume of 161 million shares / Trading value of 101.6 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index rebounded for the first time in four days. The number of rising stocks was 330, the number of falling stocks was 216, and the unchanged stocks were 32. On June 19, the US stock market celebrated Juneteenth, which commemorates the emancipation of slaves.
Press Release on Research Paper Regarding Gyre Therapeutics F351.
We would like to inform you that our subsidiary, Gyre Therapeutics, has also issued a press release regarding the research paper on F351 that we introduced on May 30th. The release includes comments from Dr. Han-In, the CEO of Gyre Therapeutics. Please see below for details.https://ir.gyretx.com/news-releases/news-release-de
Release of research paper on Beijing Component Co., Ltd.'s F351.
We would like to inform you that our subsidiary, Peking Continent, has released a news about the research paper on F351 that we introduced on May 30. According to this news, it describes the possibility of improvement due to liver fibrosis and that the number of liver fibrosis patients in China is up to 150 million. For more information, please refer to the following link: https://mp.weixin.qq.com/s/baPNON7WL-ba0S0MWhFirQ
The TOPIX index saw a slight decline after 7 days and regained some stability in the afternoon.
Tokyo Stock Exchange Growth Market Index 822.44 -0.28 / Volume 176,140,000 shares / Trading value 137.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 638.23 -0.50 / Volume 116,600,000 shares / Trading value 114.3 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, have seen a slight decline for the first time in seven days. The number of rising stocks was 202, the number of falling stocks was 333, and the unchanged ones were 39. On the 14th, the Dow average in the US market fell 57.94 dollars to 3858.
The growth market index ETF has broken through its 25-day moving average, and we want to maintain this level.
We hope that there will be a continuation of rebound in emerging markets this week. The growth market 250 index has risen for 6 consecutive days due to the rise of major stocks, and the investor's sentiment is also improving. It is estimated that there are few investors who handle the Growth 250 index, but as a rebound potential of the index, first of all, the May high level of 665 points should be focused on. So far, large market capitalization stocks such as TKP Inc. <3479> and GNI Group <2160> are recognized.
Article published on the creation story of GYRE in "Wall Street Insights".
An article about the birth of our subsidiary, Gyre Therapeutics, was featured on Wall Street Insights, the website for China's leading financial and business information. The interview format is conducted by the CEO. Please see below for more details. Story behind the first stock listing of the New Regulations on Overseas Listing: Experience Reference for Innovative Pharmaceutical Entrepreneurs - Wall Street Insight (wallstreetcn.com)
No Data